FINE FUNGI, SWITZERLAND

CATÉ, FRANCE

AceLink Therapeutics is a clinical-stage biopharma company with a focus on kidney diseases and genetic diseases with unmet clinical needs. Founded in 2018, AceLink is headquartered in San Francisco Bay area and has discovery and clinical development operations in US and Chuina. Our leading drug candidate AL01211 is a GCS inhibitor that offers a novel therapeutic approach for Fabry disease and other kidney diseases. AL01211 has successfully completed Ph1 clinical trial and is expected to enter phase 2 trial in patients with Fabry disease in 2022. The second drug program offers new treatment options for several neuropathic and neurodegenerative diseases. In addition to the above, our drug pipeline combines internal drug discovery, led by experienced drug development scientists, and licensing in external assets. AceLink has finished two rounds of VC fundraising.

QurAlis is bringing hope to the ALS community by developing breakthrough precision medicines for this devastating disease. Quralis' stem cell technologies generate proprietary human neuronal models that enable them to more effectively discover and develop innovative therapies for genetically validated targets. They are advancing three antisense and small molecule programs addressing sub-forms of the disease that account for the majority of patients.

Vincere develops small molecule therapeutics to improve mitochondrial quality. Natural mechanisms of mitochondrial quality control decline with age, leading to the neurodegeneration seen in Parkinson's disease which affects 10 million patients worldwide. Biology is complex with a rapidly growing body of knowledge. Proprietary simulation and AI from NeuroInitiative enables the Vinere team to move faster and synthesize new discoveries into efficient therapeutic programs.

曾担任华为主任工程师/测试部部长职务，获得软件测试6级任职资格，拥有超过20 年的软件质量保障及测试团队和项目管理经验，是华为操作系统部测试团队创建人，从无到有组建200人测试团队，支撑华为终端、无线、云计算等产品成功服务全球亿万级用户。擅长开源项目可信质量保障、智能化测试、复杂系统可靠性测试等。
Hi

康博瑞是Infosys中国董事会董事，也是Infosys副总裁，中国区销售和市场负责人。他在信息技术和制造业拥有超过28年的经验，过去16年任职于Infosys。康博瑞经常在各种行业活动中担任主要发言人，连续两年被鼎韬产业研究院评为 “中国服务外包行业十大人物” 。他还被中国国际投资促进会评为 “中国数字服务暨服务外包杰出贡献人物” ，以表彰他在中国为推动数字化转型和能力构建所做的贡献。在他的领导下，Infosys中国还荣获 “Infosys卓越奖 – 最佳交付中心” 。 康博瑞于2017年11月来到中国，负责销售和市场营销，他致力于帮助全球和中国本土客户探寻其数字化转型之旅。作为董事会成员，他负责中国区的运营及合规。在来中国之前，他已与多家大型企业和软件产品公司在中国建立了牢固的合作关系。 在移居中国之前，康博瑞在欧洲（瑞士和德国）工作，负责管理包括汽车、制造、化工和加工业等多个行业的客户。 在长达28年的职业生涯中，康博瑞不仅在组织内部管理大规模的业务转型项目，帮助提高生产力和盈利能力，同时还帮助客户进行业务转型。作为一个变革推动者，他曾帮助低绩效业务单元扭转僵局，转型成为高生产率和高利润的业务单元。他还曾担任损益管理、销售和业务发展、战略规划和执行、制造管理、项目管理和变更管理等领域的高级领导职务。 康博瑞拥有位于印度库鲁克舍特拉的国立理工学院电气工程专业的工科学士学位，以及位于印度班加罗尔的泽维尔管理与创业学院的工商管理硕士学位。

"华为云应用平台部首席技术布道师，前IBM大中华区DevOps产品线技术总监 •资深DevOps与精益/敏捷专家 •中国DevOps社区核心组织者，DevOpsDays中国核心组织者 •DevOps Professional官方授权讲师, SAFe SPC规模化敏捷咨询师, 凤凰项目DevOps沙盘官方授权教练, CSM, SAFe Agilist, Management 3.0 •《敏捷无敌之DevOps时代》作者，《DevOps业务视角》译者"

Michael Bolton is a consulting software tester and testing teacher who helps people to solve testing problems that they didn’t realize they could solve. In 2006, he became co-author (with James Bach) of Rapid Software Testing (RST), a methodology and mindset for testing software expertly and credibly in uncertain conditions and under extreme time pressure. Since then, he has flown over a million miles to teach RST in 35 countries on six continents. Michael has over 30 years of experience testing, developing, managing, and writing about software. For over 20 years, he has led DevelopSense, a Toronto-based testing and development consultancy. Prior to that, he was with Quarterdeck Corporation for eight years, during which he managed the company’s flagship products and directed project and testing teams both in-house and around the world. Michael Bolton国际著名的软件测试员顾问和测试讲师。《快速软件测试》的作者之一（另一名作者是James Bach），该书提供了一套帮助专业测试人员在测试资源、产品相关信息和时间都不充裕的情况下如何快速有效开展测试的方法和思维模式。 Michael 在软件测试、开发、管理和编程等方面拥有超过30年的经验。他曾在Quarterdeck Corporation工作了八年，负责管理该公司在国内和全世界的旗舰产品、定向项目以及测试团队。目前，他在多伦多经营DevelopSense咨询公司，为各种软件和网络开发项目的公司提供培训和咨询服务。